• ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemo... 4/2/2024
• ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemo... 3/28/2024
• ProBioGen Partners with MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afu... 3/14/2024
• ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production 1/23/2023
• ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technol... 1/11/2023
• ProBioGen Celebrates "A New Dawn in Biotechnology" 10/6/2022